课题基金 / 基金详情

Does Glycine Catabolism play a role in Age-Related Metabolic Disease?

Does Glycine Catabolism play a role in Age-Related Metabolic Disease?
甘氨酸分解代谢在与年龄相关的代谢疾病中起作用吗?
批准号:
9764213
负责人:
Todd A Leff
金额:
$18.42万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-08-15 至 2022-06-30

项目摘要

项目成果

Todd A Leff的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结/摘要 包括糖尿病在内的糖尿病相关疾病已取代传染病,成为糖尿病的主要原因。 发达国家的死亡。迫切需要确定新的分子靶点, 更好的治疗和诊断策略来治疗这些疾病。大量研究 表明,胰岛素抵抗和糖尿病状态的高度预测性代谢特征是一种 在循环中的甘氨酸水平的可再现的和显著的降低。这些观察提出了 一个有趣的可能性,即异常甘氨酸代谢和 糖尿病的发展,以及甘氨酸稳态的分子途径代表了新的 糖尿病干预的分子靶点。甘氨酸在多种细胞过程中起着关键作用,如果 失调,可能会影响代谢健康和糖尿病易感性。特别地,甘氨酸是一种 细胞抗氧化剂谷胱甘肽生物合成所需的底物。保护受损 抗氧化应激由于谷胱甘肽水平下降发生在衰老过程中,被认为是 在包括2型糖尿病在内的许多年龄相关疾病的发展中起关键作用。甘氨酸水平 主要由肝甘氨酸裂解系统(GCS)控制,该系统降解甘氨酸。整体 GCS的活性在糖尿病中升高,我们的初步观察表明, GCS的限速酶甘氨酸脱羧酶(GLDC)在糖尿病动物中过度表达。 额外的初步数据表明,GLDC基因转录受转录调控, 因子SREBP 1c,已知其由胰岛素激活。根据这些观察,我们建议, 高胰岛素血症,如在胰岛素抵抗状态如肥胖中所见,诱导SREBP介导的增加 在肝GLDC基因表达中,甘氨酸降解增加,最终甘氨酸水平降低 在流通。我们进一步提出,肝甘氨酸降解的增加诱导了前馈 一系列事件,包括氧化应激增加,加剧了2型糖尿病的发展 糖尿病和其他与年龄有关的疾病。该项目的首要目标是测试该模型, 确定甘氨酸代谢和糖尿病易感性之间是否存在因果关系。这将是 通过表征实验改变的肝GLDC基因的代谢效应来完成 在瘦小鼠和肥胖小鼠中的表达。这些研究代表了探索小说的初步努力, 肝脏甘氨酸降解影响疾病易感性的潜在重要可能性,如果是真的, 将GLDC确定为2型糖尿病和其他年龄- 相关疾病。
英文摘要
Project Summary/Abstract Age-related disorders including diabetes have replaced infectious diseases as the leading cause of death in developed countries. There is an urgent need to identify new molecular targets that could lead to better therapeutic and diagnostic strategies for treatment of these disorders. Numerous studies have demonstrated that a highly predictive metabolic characteristic of insulin resistant and diabetic states is a reproducible and significant reduction in the level of glycine in circulation. These observations raise the intriguing possibility that there may be a causal relationship between aberrant glycine metabolism and the development of diabetes, and that the molecular pathways underling glycine homeostasis represent novel molecular targets for diabetes intervention. Glycine plays a key role in multiple cellular processes that, if dysregulated, could influence metabolic health and diabetes susceptibility. In particular, glycine is a required substrate for the biosynthesis of the cellular antioxidant glutathione. Compromised protection against oxidative stress due to a decline in the level of glutathione occurs during aging and is thought to play a key role in the development of many age-related disorders including type 2 diabetes. Glycine levels are controlled primarily by the hepatic glycine cleavage system (GCS), which degrades glycine. The overall activity of the GCS is elevated in diabetes and our preliminary observations indicate that the gene for the rate-limiting enzyme of the GCS, glycine decarboxylase (GLDC), is over-expressed in diabetic animals. Additional preliminary data demonstrate that GLDC gene transcription is regulated by the transcription factor SREBP1c, which is known to be activated by insulin. Based on these observations, we propose that hyperinsulinemia, as seen in insulin resistant states such as obesity, induces an SREBP-mediated increase in hepatic GLDC gene expression, increased glycine degradation, and ultimately reduced levels of glycine in circulation. We further propose that the increase in hepatic glycine degradation induces a feed-forward cascade of events, including increased oxidative stress, that exacerbates the development of type 2 diabetes and other age-related diseases. The overarching goal of this project is to test this model and determine if there is a causal link between glycine metabolism and diabetes susceptibility. This will be accomplished by characterizing the metabolic effects of experimentally altered hepatic GLDC gene expression in lean and obese mice. These studies represent an initial effort to explore the novel and potentially important possibility that hepatic glycine degradation affects disease susceptibility, which if true, would identify GLDC as a potential target for therapeutic intervention for type 2 diabetes and other age- related diseases.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Metabolic Regulation of Gene Expression by AMP-Kinase
  • 批准号:
    6752937
  • 项目类别:
  • 资助金额:
    $27.71万
  • 财政年份:
    2003
  • 负责人:
    Todd A Leff
  • 依托单位:
Metabolic Regulation of Gene Expression by AMP-Kinase
  • 批准号:
    6895422
  • 项目类别:
  • 资助金额:
    $27.71万
  • 财政年份:
    2003
  • 负责人:
    Todd A Leff
  • 依托单位:
Metabolic Regulation of Gene Expression by AMP-Kinase
  • 批准号:
    6679174
  • 项目类别:
  • 资助金额:
    $29.75万
  • 财政年份:
    2003
  • 负责人:
    Todd A Leff
  • 依托单位:
REGULATION OF APOLIPOPROTEIN CIII
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: